
Coronavirus disease (COVID-19)
Aug 9, 2023 · WHO fact sheet on coronavirus disease (COVID-19), including symptoms, treatment, prevention and WHO's response.
مرض فيروس كورونا (كوفيد-19)
ومن بين عواقب مرض كوفيد-19 الوخيم الوفاة والفشل التنفسي والإنتان والانصمام الخثاري (تخثر الدم) وفشل أعضاء متعددة، بما في ذلك إصابة القلب أو الكبد أو الكلى.
Maladie à coronavirus 2019 (COVID-19) : ce qu'il faut savoir
La COVID-19 est une maladie causée par un coronavirus appelé SARS-CoV-2. L’OMS a appris l’existence de ce nouveau virus pour la première fois le 31 décembre 2019, lorsqu’un foyer …
Coronavirus Disease (COVID-19) Situation Reports
Oct 9, 2024 · The Weekly Epidemiological Update provides an overview of the global, regional and country-level COVID-19 cases and deaths, highlighting key data and trends; as well as …
Advice for the public on COVID-19 – World Health Organization
Mar 18, 2023 · This page includes advice from WHO on ways to protect yourself and prevent the spread of COVID-19. The downloadable infographics below provide guidance on general and …
Post COVID-19 condition (long COVID)
Feb 26, 2025 · WHO fact sheet on post COVID-19 condition (long COVID), including key facts, scope of the problem, symptoms, treatment, self-care and prevention.
Enfermedad por coronavirus (COVID-19)
La COVID-19 es una enfermedad causada por el coronavirus SARS-CoV-2. Por lo general, se propaga entre personas que están en contacto directo.
COVID-19 epidemiological update – 14 March 2025
Mar 17, 2025 · Twenty-three (10%) countries reported COVID-19 deaths, and 83 (35%) countries reported COVID-19 cases globally during the 28-day period from 6 January to 2 February …
COVID-19 Global Risk Assessment
Dec 31, 2024 · Since January 2020, WHO conducted global risk assessments for COVID-19 every three months. With the lifting of the public health emergency of international concern, …
Statement on the antigen composition of COVID-19 vaccines
May 15, 2025 · The TAG-CO-VAC reconvened on 6-7 May 2025 to review the genetic and antigenic evolution of SARS-CoV-2; immune responses to SARS-CoV-2 infection and/or …